Medicare Final CAR-T Policy Eases Coverage Requirements

 
• By Cathy Kelly

Product developers and researchers applaud the changes, including dropping "coverage with evidence development" approach.

T cells
CAR-T Treatment Access No Longer Theatened By Policy

More from Market Access

More from Pink Sheet